Literature DB >> 29672814

[Long-Term Survival of Patients with Colon and Rectum Carcinomas: Is There a Difference Between Cancer Centers and Non-Certified Hospitals?]

Vinzenz Völkel1, Teresa Draeger1, Michael Gerken1, Alois Fürst2, Monika Klinkhammer-Schalke1.   

Abstract

AIM OF THE STUDY: Hospitals specializing in the treatment of colorectal carcinoma with high quality standards can apply for certification as colorectal cancer centers. The aim of this study was to clarify if there is a substantial difference between certified and non-certified hospitals in terms of long-term survival of patients.
METHODS: This is a population-based retrospective cohort study using the data of a clinical cancer registry (Tumorzentrum Regensburg) which covers a southern German region of approximately 1.1 million inhabitants. 4302 patients with colorectal carcinoma who underwent radically surgery between 2004 and 2013 were divided into 4 groups for comparing certified and non-certified centers as well as the situation before and after certification. 3-year overall survival is displayed using Kaplan-Meier analysis, multivariate cox regression and relative survival models. Sensitivity analysis for missing data was conducted.
RESULTS: The estimated 3-year survival rates of patients treated at certified compared to non-certified centers were 71.6% and 63.6%, respectively. Even after adjusting for possible confounders, treatment at certified centers was associated with significant survival benefits for patients (HR=0.808, CI: 0.665-0.982). Comparison of colorectal cancer centers before and after certification showed almost identical 3-year survival rates. Cox regression analysis also showed no substantial difference between the two (HR=0.964, CI: 0.848-1.096).
CONCLUSION: Patients with colorectal cancer treated in certified compared to non-certified centers show long-term survival benefits. Patients of certified colorectal cancer centers show long-term survival benefits compared to those treated at non-certified centers. Early and successful implementation of high quality standards could explain why survival rates before and after certification do not differ. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 29672814     DOI: 10.1055/a-0591-3827

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  6 in total

1.  From quality management to quality improvement-structures, processes and outcomes.

Authors:  Simone Wesselmann; Martin Burchardt; Christoph Kowalski
Journal:  World J Urol       Date:  2021-01       Impact factor: 4.226

2.  Association of certification, improved quality and better oncological outcomes for rectal cancer in a specialized colorectal unit.

Authors:  Annika Jacob; Wolfgang Albert; Thomas Jackisch; Christiane Jakob; Anja Sims; Helmut Witzigmann; Sören Torge Mees; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2020-11-09       Impact factor: 2.571

3.  Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study.

Authors:  Martin Roessler; Jochen Schmitt; Christoph Bobeth; Michael Gerken; Kees Kleihues-van Tol; Christoph Reissfelder; Bettina M Rau; Marius Distler; Pompiliu Piso; Christian Günster; Monika Klinkhammer-Schalke; Olaf Schoffer; Veronika Bierbaum
Journal:  BMC Cancer       Date:  2022-06-07       Impact factor: 4.638

4.  Is there a clinical benefit from prostate cancer center certification? An evaluation of functional and oncologic outcomes from 22,649 radical prostatectomy patients.

Authors:  Marius Cristian Butea-Bocu; Guido Müller; Daniel Pucheril; Eckhard Kröger; Ullrich Otto
Journal:  World J Urol       Date:  2020-08-26       Impact factor: 4.226

5.  German oncology certification system for colorectal cancer - relative survival rates of a single certified centre vs. national and international registry data.

Authors:  Maximilian Richter; Lena Sonnow; Amir Mehdizadeh-Shrifi; Axel Richter; Rainer Koch; Alexander Zipprich
Journal:  Innov Surg Sci       Date:  2021-04-30

6.  Causes of mortality in elderly UICC stage III colon cancer (CC) patients--Tumor-related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry.

Authors:  Stefanie Nöpel-Dünnebacke; Hendrick Jütte; Robin Denz; Inke Sabine Feder; Anna-Lena Kraeft; Celine Lugnier; Christian Teschendorf; Daniela Collette; Hinrich Böhner; Lars Engel; Lothar Mueller; Frank Hartmann; Ulrich Kaiser; Harald-Robert Bruch; Stephan Hollerbach; Dirk Arnold; Nina Timmesfeld; Andrea Tannapfel; Anke Reinacher-Schick
Journal:  Cancer Med       Date:  2022-02-11       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.